XML 13 R7.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Interim Condensed Consolidated Statements of Changes in Shareholders' Equity (Unaudited) - USD ($)
$ in Thousands
Total
Common Stock [Member]
Additional Paid-in Capital [Member]
Accumulated Other Comprehensive Loss [Member]
Retained Earnings [Member]
Treasury Stock [Member]
Beginning balance, value at Dec. 31, 2022 $ 85,135 $ 75 $ 14,510 $ (7,241) $ 104,460 $ (26,669)
Balance (in shares) at Dec. 31, 2022   5,812,258        
Net income 2,072       2,072  
Net change in fair value of securities available-for-sale, net of tax (313)     (313)    
Net change in fair value of derivative instruments, net of tax (160)     (160)    
Dividends declared (294)       (294)  
Impact of stock-based compensation plans, net 128   153     (25)
Impact of stock-based compensation plans, net (in shares)   54,608        
Ending balance, value at Mar. 31, 2023 84,757 $ 75 14,663 (7,714) 104,427 (26,694)
Ending balance, value (Impact of Adopting CECL [Member]) at Mar. 31, 2023 (1,811)       (1,811)  
Balance (in shares) at Mar. 31, 2023   5,866,866        
Beginning balance, value at Dec. 31, 2023 90,593 $ 75 14,972 (6,431) 109,959 (27,982)
Balance (in shares) at Dec. 31, 2023   5,735,075        
Net income 2,107       2,107  
Net change in fair value of securities available-for-sale, net of tax (73)     (73)    
Net change in fair value of derivative instruments, net of tax (117)     (117)    
Dividends declared (289)       (289)  
Impact of stock-based compensation plans, net 105   150     (45)
Impact of stock-based compensation plans, net (in shares)   52,366        
Ending balance, value at Mar. 31, 2024 $ 92,326 $ 75 $ 15,122 $ (6,621) $ 111,777 $ (28,027)
Balance (in shares) at Mar. 31, 2024   5,787,441